Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Chinese Acupuncture & Moxibustion ; (12): 162-164, 2011.
Artigo em Chinês | WPRIM | ID: wpr-322627

RESUMO

The history of collateral puncture therapy in Japan was traced, the current status and characteristics of collateral puncture therapy in Japan were introduced in this paper. Originated in China, the collateral puncture therapy in Japan combined Japanese knowledge of acupuncture with the theory and practice of bloodletting of Portugal Medicine and Netherlands Medicine. The discussion on the theory and technique of the collateral puncture therapy by Kudo Kunsei became the standard of the collateral puncture therapy in Japan in modern times. Based on this discussion, Tetuo Asami proposed a new theory of the collateral puncture therapy which improved the collateral puncture therapy in Japan. Currently, as a part of Japanese health care system, the collateral puncture therapy with Japanese characteristics is gradually accepted by the medical profession in Japan.


Assuntos
Humanos , Pontos de Acupuntura , Sangria , História , Métodos , História do Século XV , História do Século XVII , História do Século XVIII , História do Século XIX , Japão , Medicina Tradicional do Leste Asiático , Meridianos
2.
China Journal of Chinese Materia Medica ; (24): 1346-1348, 2005.
Artigo em Chinês | WPRIM | ID: wpr-239681

RESUMO

<p><b>OBJECTIVE</b>To observe the rate of Zijin powder in inhibiting H22 mice solid and ascites liver cancer and the relation between quatity and effect.</p><p><b>METHOD</b>The Kunming mics, transplanted by H22 liver cells, were divided into a model group, a cyclophosphamide group and three groups of Zijin powder in high dose, medium dose, and low dose. Then observation was made on the rate of Cancer.</p><p><b>RESULT</b>The inhibiting rates of Zijin powder of three groups (high dose group, medium dose group and low dose group) for H22 mice solid liver cancer were 30.8%, 38.31% and 48.59% respectivily. The inhibiting rates of three groups of Zijin powder (low dose group, medium dose and high dose group) for H22 mice ascites liver cancer were 6.77%, 15.59% and 14.90 % respectivily.</p><p><b>CONCLUSION</b>Zijin powder has better effect on H22 mice solid liver cancer, and its effect is greatly increasing with the increased dosage.</p>


Assuntos
Animais , Feminino , Humanos , Masculino , Camundongos , Antineoplásicos Fitogênicos , Farmacologia , Usos Terapêuticos , Relação Dose-Resposta a Droga , Medicamentos de Ervas Chinesas , Farmacologia , Neoplasias Hepáticas , Tratamento Farmacológico , Fitoterapia , Pós , Distribuição Aleatória
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA